Neuropsychiatric Disorders and Epigenetics 2nd Edition

Neuropsychiatric Disorders and Epigenetics, 2nd Edition by Jacob Peedicayil and Dennis R. Grayson is a definitive, up-to-date resource bridging molecular science and clinical practice. Ideal for psychiatrists, neuroscientists, clinical researchers, and advanced students, this edition distills cutting-edge epigenetic discoveries into clear implications for diagnosis, treatment, and research across neuropsychiatric disorders.

Start here to understand how DNA methylation, histone modification, and non-coding RNAs shape brain development and influence conditions such as schizophrenia, bipolar disorder, depression, autism spectrum disorders, and neurodegenerative disease. The authors synthesize genetic, epigenomic, and environmental evidence to explain disease mechanisms and therapeutic targets, making complex science accessible without sacrificing rigor.

What sets this second edition apart is its emphasis on translational relevance: enhanced chapters on biomarkers, epigenetic epidemiology, and novel therapeutic strategies show how laboratory insights are moving toward clinical application. Each chapter pairs mechanistic detail with real-world perspectives on patient care, research design, and drug development—valuable for clinicians in the United States, Europe, Asia, and beyond who seek practical guidance informed by the latest global research.

Whether you’re designing a study, updating clinical protocols, or deepening your conceptual toolkit, this book provides actionable knowledge and a comprehensive reference to the evolving field of psychiatric epigenetics.

Bring clarity to complex neurobiology and stay at the forefront of psychiatric research—order your copy of Neuropsychiatric Disorders and Epigenetics, 2nd Edition today and equip your practice or lab with an essential, authoritative guide.

Note: eBooks do not include supplementary materials such as CDs, access codes, etc.